Targeting Smad-Mediated TGFß Pathway in Coronary Artery Bypass Graft.

Ungogo, Marzuq A

Ungogo, Marzuq A.

Affiliation

Ungogo MA; Department of Veterinary Pharmacology and Toxicology, 58989Ahmadu Bello University, Zaria, Nigeria.

J Cardiovasc Pharmacol Ther ; 26(2): 119-130, 2021 03.

Article in En | MEDLINE | ID: mdl-32812447

Subject(s)

Activin Receptors, Type II/metabolism; Graft Occlusion, Vascular/physiopathology; Receptor, Transforming Growth Factor-beta Type I/metabolism; Transforming Growth Factor beta/metabolism; Coronary Artery Bypass; Coronary Disease/surgery; Humans; Hyperplasia/physiopathology; Myocytes, Smooth Muscle; Signal Transduction; Smad2 Protein

Key words

ALK; TGFß; coronary bypass graft; restenosis; smad

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transforming Growth Factor beta / Activin Receptors, Type II / Receptor, Transforming Growth Factor-beta Type I / Graft Occlusion, Vascular Limits: Humans Language: En Journal: J Cardiovasc Pharmacol Ther Journal subject: ANGIOLOGIA / CARDIOLOGIA / FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: Nigeria Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google